
As specialty drug complexity grows, agentic technology puts the right access, adherence, and affordability resources at the provider’s fingertips at prescribing.
A recent report from Global Market Insights, Inc. shows that the in-vitro diagnostic services market is predicted to grow from its current market value of $44 billion to over $63 billion by 2024.
Developments in diagnostic tests will enhance in-vitro diagnostic services industry growth over the coming years. Integration of advanced technology within the diagnostic devices should propel in-vitro diagnostic services market growth in the upcoming years.






